Kuraray (3405) Investor Day 2025 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2025 summary
19 Jun, 2025Strategic direction and business overview
Focus on growth opportunities in the PVOH resin business, leveraging a global supply chain and integrated production system across the US, Europe, and Asia.
Emphasis on R&D throughout the value chain, from raw materials to advanced processed products, to maintain technical leadership.
Six global production sites with a total PVOH resin capacity of 361,000 tons, supported by a robust sales and technical service network.
Establishment of a new technical center in Singapore to strengthen technical services in Asia.
Market trends and product innovation
Rising demand for eco-friendly, PFAS-free, and microplastic-free solutions is driving product development.
High-performance products like EXCEVAL™ and specialized KURARAY POVAL™ grades target applications in gas barrier paper, grease proof paper, and high-porosity PVC dispersants.
EXCEVAL™ sales have accelerated globally since 2017, with adoption increasing in Europe for sustainable packaging.
Formaldehyde-free and high water resistance adhesives, as well as differentiated products for detergent unit dose systems, are expanding.
Financial guidance and growth outlook
High-performance product sales are projected to grow at a CAGR of 8% from 2024 to 2030.
Growth is driven by demand in Asia for PVC resin, expansion in packaging, electronic materials, and agricultural coatings.
Capacity expansion and new product launches are planned to solidify market position in Asia.
Latest events from Kuraray
- FY2025 profit dropped on impairments, but FY2026 forecasts a strong rebound and higher dividends.3405
Q4 202610 Feb 2026 - SentryGlas® dominates structural glass with high performance and sustainability, driving global growth.3405
Investor Update19 Dec 2025 - Profits fell over 50% year-over-year; forecasts cut and major share buyback completed.3405
Q3 202612 Nov 2025 - Profits and sales fell in 1H FY2025, but portfolio restructuring and buybacks advanced.3405
Q2 20268 Aug 2025 - Profits and shareholder returns rose, with robust guidance despite lower sales forecast.3405
Q3 202513 Jun 2025 - Record interim results and upgraded outlook, with increased dividends and share buybacks.3405
Q2 202513 Jun 2025 - Sales up, profits down; full-year outlook steady, major share buyback planned.3405
Q1 20266 Jun 2025 - Record sales and operating income, but net income fell on extraordinary losses; profit recovery forecast.3405
Q4 20255 Jun 2025